Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Non adherence to treatment and the associated factors in patients with epilepsy in Southern Ethiopia

View through CrossRef
Adherence to antiepileptic drug therapy in people with epilepsy is critical for seizure control. Poor adherence to epilepsy treatment, on the other hand, is recognized as a worldwide problem, particularly in developing countries such as Ethiopia. As a result, the current study seeks to ascertain patients’ adherence to antiepileptic medications and the factors that influence it at Hawassa University Comprehensive Specialized Hospital in Southern Ethiopia. From February 1 to October 15, 2017, 187 people with epilepsy who were on followup at Hawassa University Comprehensive Specialized Hospital underwent a hospitalbased retrospective medical review. Adherence was measured using Morisky Medication Scale-8. Data was entered and analyzed using the soft ware Statistical package for social sciences version 20. The results were summarized using cross-tabulations and frequency tables. While binary logistic regression was used to analyze factors associated with adherence to antiepileptic drug therapy, significance was declared at p<0.05. According to the findings of the current study, about nineteen percent of the study participants were nonadherent to their treatment. Compared to patients with monthly income of less than 1000.00 ETB, those who earn>3000.00 ETB [AOR=0.164, 95% CI (0.038: 0.702)] and those with monthly income between 2000 and 3000 ETB [AOR=0.110, 95%CI (0.026:0.461)] [AOR=0.110, 95% CI (0.026:0.461)] are less likely associated with non-adherent to antiepileptic drugs (P<0.05). Likewise, patients who perceived epilepsy as psychiatric disorder [AOR= 0.250, 95%CI (0.087: 0.716)] compared to those who perceive it as neurologic, and those patients with seizure free period of less than one year [AOR= 0.206, 95%CI(0.076:0.562)] compared to those with seizure free period of more than one year are found to be less non adherent (p<0.05).
Title: Non adherence to treatment and the associated factors in patients with epilepsy in Southern Ethiopia
Description:
Adherence to antiepileptic drug therapy in people with epilepsy is critical for seizure control.
Poor adherence to epilepsy treatment, on the other hand, is recognized as a worldwide problem, particularly in developing countries such as Ethiopia.
As a result, the current study seeks to ascertain patients’ adherence to antiepileptic medications and the factors that influence it at Hawassa University Comprehensive Specialized Hospital in Southern Ethiopia.
From February 1 to October 15, 2017, 187 people with epilepsy who were on followup at Hawassa University Comprehensive Specialized Hospital underwent a hospitalbased retrospective medical review.
Adherence was measured using Morisky Medication Scale-8.
Data was entered and analyzed using the soft ware Statistical package for social sciences version 20.
The results were summarized using cross-tabulations and frequency tables.
While binary logistic regression was used to analyze factors associated with adherence to antiepileptic drug therapy, significance was declared at p<0.
05.
According to the findings of the current study, about nineteen percent of the study participants were nonadherent to their treatment.
Compared to patients with monthly income of less than 1000.
00 ETB, those who earn>3000.
00 ETB [AOR=0.
164, 95% CI (0.
038: 0.
702)] and those with monthly income between 2000 and 3000 ETB [AOR=0.
110, 95%CI (0.
026:0.
461)] [AOR=0.
110, 95% CI (0.
026:0.
461)] are less likely associated with non-adherent to antiepileptic drugs (P<0.
05).
Likewise, patients who perceived epilepsy as psychiatric disorder [AOR= 0.
250, 95%CI (0.
087: 0.
716)] compared to those who perceive it as neurologic, and those patients with seizure free period of less than one year [AOR= 0.
206, 95%CI(0.
076:0.
562)] compared to those with seizure free period of more than one year are found to be less non adherent (p<0.
05).

Related Results

Portrait of Epilepsy on the Canvas of Global Health
Portrait of Epilepsy on the Canvas of Global Health
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. GBD Epilepsy Collabora...
River Epilepsy—A Preventable Form of Epilepsy
River Epilepsy—A Preventable Form of Epilepsy
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan: A 3-Year Longitudinal, Prospective, Population-Based Study. ...
The pattern of knowledge, attitude, and practice of epilepsy in Bengali-speaking literate epilepsy patients in Kolkata
The pattern of knowledge, attitude, and practice of epilepsy in Bengali-speaking literate epilepsy patients in Kolkata
Background: A good knowledge, attitude, and practice (KAP) are lacking among epilepsy patients and the general public (even literates) across the world. As a result, a treatment ga...
The adherence gap: Rural dwelling, low level of education, and missed opportunities for optimal hepatitis B control
The adherence gap: Rural dwelling, low level of education, and missed opportunities for optimal hepatitis B control
Background and Objectives: Long-term antiviral use can suppress hepatitis B virus (HBV) DNA, normalize liver function tests, reverse fibrosis and cirrhosis, and improve histologica...
Unraveling the role of non-coding rare variants in epilepsy
Unraveling the role of non-coding rare variants in epilepsy
AbstractImportanceDespite the use of very large cohorts, the discovery of new variants has leveled off in recent years in epilepsy studies and consequently, most of the heritabilit...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

Back to Top